Comment to FDA on Food Additive Petition for Erythromycin Thiocyanate (Animal Use)

Comments to the FDA regarding the North American Bioproducts Corp. (NABC) Food Additive Petition for Erythromycin Thiocyanate (Animal Use) and recommending that the FDA not approve the addition of the critically important human drug erythromycin to animal feed due to the risk to public health from the development of antimicrobial resistance.  

Group Letter Urging President Obama to Support The Preservation of Antibiotics for Medical Treatment Act (PAMTA) of 2009

To meet the challenge of the misuse of antibiotics effectively, FDA must address the full range of nontherapeutic uses. Addressing only the growth promotion and feed efficiency uses of antibiotics, estimated by industry to be just 10 to 15 percent of the total, would make only a minor dent in the problem.

Group Letter to FDA Commissioner Dr. Margaret Hamburg on Antibiotic-Resistant Microorganisms

The steering committee of Keep Antibiotics Working met with FDA Commissioner Dr, Margaret Hamburg to discuss the Food and Drug Administration’s response to the urgent and growing crisis of antibiotic-resistant microorganisms.This letter was sent after after the meeting as a review and to further specific points covered in the meeting.

Group Letter to FDA Requesting Immediate Action on Cephalosporins

Group letter to the FDA requesting asking immediate action addressing the risks to human and animal health resulting from the inappropriate use of antimicrobial drugs in food producing animals by:         1) Making a final decision against the approval of cefquinome for use in food-producing animals,